Review: taking Adderall xr 30 and Magnesium sulfate together


Summary

Drug interactions are reported among people who take Adderall xr 30 and Magnesium sulfate together. This review analyzes the effectiveness and drug interactions between Adderall xr 30 and Magnesium sulfate. It is created by eHealthMe based on reports of 43 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Adderall xr 30 and Magnesium sulfate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Adderall Xr 30

Adderall xr 30 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall xr 30 1,140 users)

Magnesium Sulfate

Magnesium sulfate has active ingredients of magnesium sulfate. It is often used in constipation. (latest outcomes from Magnesium sulfate 7,568 users)

On Aug, 28, 2016

43 people who take Adderall Xr 30, Magnesium Sulfate are studied.


Number of reports submitted per year:

Adderall xr 30 and Magnesium sulfate drug interactions.

Drug effectiveness over time:

Adderall Xr 30:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (2 of 2 people)
  • 2 - 5 years: 75.0% - (3 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 1 people)
Magnesium Sulfate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Adderall Xr 30:
  • female: 70.0% - (7 of 10 people)
  • male: 0.0% - (0 of 0 people)
Magnesium Sulfate:
  • female: 22.0% - (2 of 9 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Adderall Xr 30:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 0.0% - (0 of 1 people)
Magnesium Sulfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 25.0% - (1 of 4 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • blood pressure increased
1 - 6 months:
  • blood pressure increased
  • recurring skin boils
  • tiredness
  • weight gain
6 - 12 months:
  • mood swings
2 - 5 years:
  • angioedema
  • stuffy nose
  • eye degenerative disorder
  • mood swings
  • myoclonic jerks
  • recurring skin boils
  • suicidal ideation
  • tiredness
  • weight gain
not specified:
  • haematochezia
  • blood alkaline phosphatase increased
  • encephalopathy
  • hyperbilirubinaemia
  • hypoxia
  • pleural effusion
  • respiratory distress
  • staphylococcal infection
  • alanine aminotransferase increased
  • fall

Most common drug interactions by gender *:

female:
  • back pain
  • gastritis
  • insomnia
  • muscle spasms
  • nausea
  • vertigo
  • anxiety
  • diarrhoea
  • fatigue
  • haemorrhoids
male:
  • blood alkaline phosphatase increased
  • encephalopathy
  • haematochezia
  • hyperbilirubinaemia
  • hypoxia
  • pleural effusion
  • respiratory distress
  • staphylococcal infection
  • alanine aminotransferase increased
  • meningitis bacterial

Most common drug interactions by age *:

10-19:
  • blood alkaline phosphatase increased
  • haematochezia
  • hyperbilirubinaemia
  • pleural effusion
  • respiratory distress
  • staphylococcal infection
  • alanine aminotransferase increased
  • encephalopathy
  • hypoxia
  • meningitis bacterial
30-39:
  • nausea
  • dehydration
  • dizziness
  • feeling abnormal
  • gastritis
  • hypokalaemia
  • lethargy
  • middle insomnia
  • muscle spasms
  • oesophagitis
40-49:
  • recurring skin boils
  • tiredness
  • weight gain
  • angioedema
50-59:
  • back pain
  • insomnia
  • anxiety
  • diarrhoea
  • fatigue
  • haemorrhoids
  • attention deficit/hyperactivity disorder
  • cataract
  • chest discomfort
  • constipation
60+:
  • colon cancer metastatic
  • hypophosphataemia
  • metastases to liver
  • colonic polyp

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Adderall xr 30 and Magnesium sulfate?

Can you answer these questions?

More questions for: Adderall xr 30, Magnesium sulfate

You may be interested in these reviews

More reviews for: Adderall xr 30, Magnesium sulfate

On eHealthMe, Adderall xr 30 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Magnesium sulfate (magnesium sulfate) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.